Cargando…
Decreased expression of the Id3 gene at 1p36.1 in ovarian adenocarcinomas
The molecular events that drive the initiation and progression of ovarian adenocarcinoma are not well defined. We have investigated changes in gene expression in ovarian cancer cell lines compared to an immortalized human ovarian surface epithelial cell line (HOSE) using a cDNA array. We identified...
Autores principales: | , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2001
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2363740/ https://www.ncbi.nlm.nih.gov/pubmed/11161400 http://dx.doi.org/10.1054/bjoc.2000.1620 |
_version_ | 1782153779664125952 |
---|---|
author | Arnold, J M Mok, S C Purdie, D Chenevix-Trench, G |
author_facet | Arnold, J M Mok, S C Purdie, D Chenevix-Trench, G |
author_sort | Arnold, J M |
collection | PubMed |
description | The molecular events that drive the initiation and progression of ovarian adenocarcinoma are not well defined. We have investigated changes in gene expression in ovarian cancer cell lines compared to an immortalized human ovarian surface epithelial cell line (HOSE) using a cDNA array. We identified 17 genes that were under-expressed and 10 genes that were over-expressed in the cell lines compared to the HOSE cells. One of the genes under-expressed in the ovarian cancer cell lines, Id3, a transcriptional inactivator, was selected for further investigation. Id3 mRNA was expressed at reduced levels in 6 out of 9 ovarian cancer cell lines compared to the HOSE cells while at the protein level, all 7 ovarian cancer cell lines examined expressed the Id3 protein at greatly reduced levels. Expression of Id3 mRNA was also examined in primary ovarian tumours and was found in only 12/38 (32%) cases. A search was conducted for mutations of Id3 in primary ovarian cancers using single stranded conformation polymorphism (SSCP) analysis. Only one nucleotide substitution, present also in the corresponding constitutional DNA, was found in 94 ovarian tumours. Furthermore no association was found between LOH at 1p36 and lack of expression of Id3. These data suggest that Id3 is not the target of LOH at 1p36. © 2001 Cancer Research Campaign http://www.bjcancer.com |
format | Text |
id | pubmed-2363740 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2001 |
publisher | Nature Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-23637402009-09-10 Decreased expression of the Id3 gene at 1p36.1 in ovarian adenocarcinomas Arnold, J M Mok, S C Purdie, D Chenevix-Trench, G Br J Cancer Regular Article The molecular events that drive the initiation and progression of ovarian adenocarcinoma are not well defined. We have investigated changes in gene expression in ovarian cancer cell lines compared to an immortalized human ovarian surface epithelial cell line (HOSE) using a cDNA array. We identified 17 genes that were under-expressed and 10 genes that were over-expressed in the cell lines compared to the HOSE cells. One of the genes under-expressed in the ovarian cancer cell lines, Id3, a transcriptional inactivator, was selected for further investigation. Id3 mRNA was expressed at reduced levels in 6 out of 9 ovarian cancer cell lines compared to the HOSE cells while at the protein level, all 7 ovarian cancer cell lines examined expressed the Id3 protein at greatly reduced levels. Expression of Id3 mRNA was also examined in primary ovarian tumours and was found in only 12/38 (32%) cases. A search was conducted for mutations of Id3 in primary ovarian cancers using single stranded conformation polymorphism (SSCP) analysis. Only one nucleotide substitution, present also in the corresponding constitutional DNA, was found in 94 ovarian tumours. Furthermore no association was found between LOH at 1p36 and lack of expression of Id3. These data suggest that Id3 is not the target of LOH at 1p36. © 2001 Cancer Research Campaign http://www.bjcancer.com Nature Publishing Group 2001-02 /pmc/articles/PMC2363740/ /pubmed/11161400 http://dx.doi.org/10.1054/bjoc.2000.1620 Text en Copyright © 2001 Cancer Research Campaign https://creativecommons.org/licenses/by/4.0/This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material.If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit https://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Regular Article Arnold, J M Mok, S C Purdie, D Chenevix-Trench, G Decreased expression of the Id3 gene at 1p36.1 in ovarian adenocarcinomas |
title | Decreased expression of the Id3 gene at 1p36.1 in ovarian adenocarcinomas |
title_full | Decreased expression of the Id3 gene at 1p36.1 in ovarian adenocarcinomas |
title_fullStr | Decreased expression of the Id3 gene at 1p36.1 in ovarian adenocarcinomas |
title_full_unstemmed | Decreased expression of the Id3 gene at 1p36.1 in ovarian adenocarcinomas |
title_short | Decreased expression of the Id3 gene at 1p36.1 in ovarian adenocarcinomas |
title_sort | decreased expression of the id3 gene at 1p36.1 in ovarian adenocarcinomas |
topic | Regular Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2363740/ https://www.ncbi.nlm.nih.gov/pubmed/11161400 http://dx.doi.org/10.1054/bjoc.2000.1620 |
work_keys_str_mv | AT arnoldjm decreasedexpressionoftheid3geneat1p361inovarianadenocarcinomas AT moksc decreasedexpressionoftheid3geneat1p361inovarianadenocarcinomas AT purdied decreasedexpressionoftheid3geneat1p361inovarianadenocarcinomas AT chenevixtrenchg decreasedexpressionoftheid3geneat1p361inovarianadenocarcinomas |